Representatives of the Candida parapsilosis complex are important yeast species causing
human infections, including candidaemia as one of the leading diseases. This complex …

The treatment of invasive fungal infections remains challenging and the emergence of new
fungal pathogens as well as the development of resistance to the main antifungal drugs …

Clonal outbreaks of fluconazole-resistant (FLZR) Candida parapsilosis isolates have been
reported in several countries. Despite its being the second leading cause of candidemia, the …

Patients presenting with severe COVID-19 are predisposed to acquire secondary fungal
infections such as COVID-19-associated candidemia (CAC), which are associated with poor …

Understanding how microbial pathogens adapt to treatments, humans and clinical
environments is key to infer mechanisms of virulence, transmission and drug resistance …

Fungal pathogens represent a major human threat affecting more than a billion people
worldwide. Invasive infections are on the rise, which is of considerable concern because …

Galleria mellonella larvae have become a widely accepted and utilised infection model due
to the functional homology displayed between their immune response to infection and that …

The Candida genus encompasses a diverse group of ascomycete fungi that have captured
the attention of the scientific community, due to both their role in pathogenesis and emerging …

Candida parapsilosis is known to cause severe and persistent outbreaks in clinical settings.
Patients infected with multidrug-resistant C. parapsilosis (MDR Cp) isolates were identified …

While being the third leading cause of candidemia worldwide, numerous studies have
shown severe clonal outbreaks due to fluconazole-resistant (FLCR) Candida parapsilosis …